Efficacy and safety of high-dose chemotherapy as second or subsequent salvage therapy in relapsed or refractory germ cell cancer patients: A multicentric analysis

被引:0
|
作者
Seidel, C. [1 ]
De Giorgi, U. F. F. [2 ]
Engel, N. [1 ]
Hentrich, M. [3 ]
Zschaebitz, S. [4 ]
Conolly, E. [5 ]
Weickhardt, A. J. [6 ]
Grimison, P. [7 ]
Wong, V. [8 ]
Oing, C. [9 ]
Alsdorf, W. [1 ]
Schaefers, C. [1 ]
Bokemeyer, C. [1 ]
Tran, B. [10 ]
机构
[1] UKE Univ Klinikum Hamburg Eppendorf KMTZ, Oncol Hematol & Bone Marrow Transplantat, Hamburg, Germany
[2] IRST Ist Romagnolo Studio Tumori Dino Amadori IRC, Med Oncol Dept, Meldola, Italy
[3] Rotkreuzklinikum Munchen, Dept Hematol & Oncol, Munich, Germany
[4] NCT Nationales Zentrum Tumorerkrankungen, Med Oncol Dept, Heidelberg, Germany
[5] Chris OBrien Lifehouse, Oncol, Sydney, NSW, Australia
[6] Olivia Newton John Canc Wellness & Res Ctr, Med Oncol Dept, Heidelberg, Vic, Australia
[7] Chris OBrien Lifehouse, Dept Med Oncol, Camperdown, NSW, Australia
[8] WEHI Walter & Eliza Hall Inst Med Res, Oncol, Parkville, Vic, Australia
[9] Newcastle Univ, Sir Bobby Robson Clin Trials Res Ctr, Newcastle Upon Tyne, England
[10] Peter MacCallum Canc Ctr, Med Oncol Dept, Melbourne, Vic, Australia
关键词
D O I
10.1016/j.annonc.2023.09.678
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
732P
引用
收藏
页码:S503 / S503
页数:1
相关论文
共 50 条
  • [41] Salvage high-dose chemotherapy in patients with germ cell tumors - An Italian experience with 84 patients
    Rosti, G
    De Giorgi, U
    Salvioni, R
    Papiani, G
    Sebastiani, L
    Argnani, M
    Monti, G
    Ferrante, P
    Pizzocaro, G
    Marangolo, M
    CANCER, 2002, 95 (02) : 309 - 315
  • [42] Single versus sequential high-dose chemotherapy (HOCT) in patients with relapsed or refractory germ-cell tumors (GCT).
    Lorch, A.
    Rick, O.
    Hartmann, J. T.
    Kollmannsberger, C.
    Metzner, B.
    Schmidt-Wolf, I.
    Berdel, W. E.
    Schirren, R.
    Beyer, J.
    Bokemeyer, C.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 219S - 219S
  • [43] Salvage high-dose chemotherapy (HDCT) for relapsed primary mediastinal nonseminomatous germ-cell tumors (PMNSGCT).
    Taza, Fadi
    Abonour, Rafat
    Althouse, Sandra K.
    Ashkar, Ryan
    Abu Zaid, Mohammad Issam
    Hanna, Nasser H.
    Kessler, Kenneth A.
    Adra, Nabil
    Einhorn, Lawrence H.
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [44] High-dose sequential chemotherapy: an effective salvage treatment for relapsed and refractory Hodgkin lymphoma
    Nassi, L
    Rigacci, L
    Guidi, S
    Alterini, R
    Carrai, V
    Lombardini, L
    Nozzoli, C
    Saccardi, R
    Vannucchi, AM
    Bosi, A
    BONE MARROW TRANSPLANTATION, 2006, 37 : S244 - S244
  • [45] High-dose chemotherapy in nonseminomatous germ cell cancer
    Kollmannsberger, Christian
    Beyer, Joerg
    Bokemeyer, Carsten
    BJU INTERNATIONAL, 2009, 104 (9B) : 1398 - 1403
  • [46] Salvage treatment for germ cell cancer after failed high-dose therapy - response
    Pont, J
    Bokemeyer, C
    ANNALS OF ONCOLOGY, 1998, 9 (07) : 788 - 788
  • [47] High-dose chemotherapy as salvage treatment in germ-cell cancer: when, in whom and how
    Anja Lorch
    Jörg Beyer
    World Journal of Urology, 2017, 35 : 1177 - 1184
  • [48] HIGH-DOSE METHOTREXATE, VINCRISTINE AND CISPLATIN AS SALVAGE TREATMENT FOR RELAPSED NONSEMINOMATOUS GERM-CELL CANCER
    SLEIJFER, S
    VANDERGRAAF, WTA
    WILLEMSE, PHB
    DEVRIES, EGE
    KOOPS, HS
    MULDER, NH
    ANTICANCER RESEARCH, 1995, 15 (03) : 1039 - 1042
  • [49] Early prediction of treatment response to high-dose salvage chemotherapy in patients with relapsed germ cell cancer using [18F]FDG PET
    C Bokemeyer
    C Kollmannsberger
    K Oechsle
    B M Dohmen
    A Pfannenberg
    C D Claussen
    R Bares
    L Kanz
    British Journal of Cancer, 2002, 86 : 506 - 511
  • [50] High-dose chemotherapy as salvage treatment in germ-cell cancer: when, in whom and how
    Lorch, Anja
    Beyer, Jorg
    WORLD JOURNAL OF UROLOGY, 2017, 35 (08) : 1177 - 1184